Active Filter(s):
Details:
The partnership aims to execute a Phase 2b clinical trial to assess the relative efficacy of a next generation COVID-19 vaccine compared to currently approved/authorised COVID-19 vaccines in the prevention of symptomatic, PCR confirmed SARS-CoV-2 infection.
Lead Product(s): Undisclosed
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Phase II Product Type: Vaccine
Partner/Sponsor/Collaborator: BARDA
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership September 13, 2023
Details:
This clinical study will inform operational logistics and will not expose participants to anthrax. AV7909 is indicated for post-exposure prophylaxis of anthrax disease. Anthrax vaccine is also recommended for unvaccinated people of all ages who have been exposed to anthrax.
Lead Product(s): AV7909
Therapeutic Area: Infections and Infectious Diseases Product Name: AV7909
Highest Development Status: Phase III Product Type: Vaccine
Partner/Sponsor/Collaborator: BARDA
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 06, 2022
Details:
The purpose of the study is to evaluate the efficacy of Evergreen’s EG-009A drug candidate for the treatment of moderate to severe COVID-19 cases.
Lead Product(s): EG-009A
Therapeutic Area: Infections and Infectious Diseases Product Name: EG-009A
Highest Development Status: Phase I Product Type: Undisclosed
Partner/Sponsor/Collaborator: Evergreen Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement June 18, 2021
Details:
All 50 patients who participated in the extension of Diamyd Medical's Phase IIb trial DIAGNODE-2 with the diabetes vaccine Diamyd® have now made their 24-month visit, and data will be presented in early July.
Lead Product(s): Recombinant human glutamic acid decarboxylase,Vitamin D
Therapeutic Area: Endocrinology Product Name: Diamyd
Highest Development Status: Phase II Product Type: Vaccine
Recipient: Diamyd Medical AB
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 29, 2021